Medpace Holdings Inc Stock
Price
Target price
€349.30
€349.30
-2.050%
-7.2
-2.050%
€399.91
19.04.24 / Tradegate
WKN: A2APTV / Symbol: MEDP / Name: Medpace Holdings / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Medpace Holdings Inc Stock
A loss of -2.050% shows a downward development for Medpace Holdings Inc.
Medpace Holdings Inc is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
As a result the target price of 399 € shows a slightly positive potential of 14.23% compared to the current price of 349.3 € for Medpace Holdings Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Medpace Holdings Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Medpace Holdings Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medpace Holdings Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | -2.050% | -6.804% | -2.837% | 97.792% | 24.306% | 131.325% | - |
| Galapagos N.V. | 0.150% | -4.902% | -11.300% | -21.092% | -26.674% | -58.503% | - |
| Novocure Ltd | -1.720% | -11.085% | -8.909% | -80.445% | -20.490% | -92.848% | - |
| Iovance Biotherapeutics Inc. | -3.130% | -8.480% | -17.018% | 99.213% | 36.142% | -58.428% | - |
Comments
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00.
Show more
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Robert W. Baird from $312.00 to $408.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MEDP provided by MarketBeat